Literature DB >> 24618733

Functional and genetic aberrations of in vitro-cultured marrow-derived mesenchymal stromal cells of patients with classical Philadelphia-negative myeloproliferative neoplasms.

M A Avanzini1, M E Bernardo2, F Novara3, M Mantelli1, V Poletto4, L Villani4, E Lenta1, D M Ingo1, V Achille1, E Bonetti4, M Massa5, R Campanelli4, G Fois4, P Catarsi4, R P Gale6, A Moretta1, A Aronica4, R Maccario1, G Acquafredda1, D Lisini7, M Zecca1, O Zuffardi3, F Locatelli2, G Barosi4, V Rosti4.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24618733     DOI： 10.1038/leu.2014.97

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates.

Authors:  Yusuke Sakaguchi; Ichiro Sekiya; Kazuyoshi Yagishita; Shizuko Ichinose; Kenichi Shinomiya; Takeshi Muneta
Journal:  Blood       Date:  2004-07-08       Impact factor: 22.113

2.  Methylation of AR locus does not always reflect X chromosome inactivation state.

Authors:  Sabina I Swierczek; Lucie Piterkova; Jaroslav Jelinek; Neeraj Agarwal; Sue Hammoud; Andrew Wilson; Kimberly Hickman; Charles J Parker; Bradley R Cairns; Bradley Cairns; Josef T Prchal
Journal:  Blood       Date:  2012-01-27       Impact factor: 22.113

3.  Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells.

Authors:  Uri Ben-David; Yoav Mayshar; Nissim Benvenisty
Journal:  Cell Stem Cell       Date:  2011-08-05       Impact factor: 24.633

4.  Unbalanced X-chromosome inactivation in haemopoietic cells from normal women.

Authors:  L Tonon; G Bergamaschi; C Dellavecchia; V Rosti; C Lucotti; L Malabarba; A Novella; E Vercesi; F Frassoni; M Cazzola
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

5.  Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells.

Authors:  S Geyh; S Oz; R-P Cadeddu; J Fröbel; B Brückner; A Kündgen; R Fenk; I Bruns; C Zilkens; D Hermsen; N Gattermann; G Kobbe; U Germing; F Lyko; R Haas; T Schroeder
Journal:  Leukemia       Date:  2013-03-29       Impact factor: 11.528

6.  Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow.

Authors:  Eugenia Flores-Figueroa; Sushama Varma; Kelli Montgomery; Peter L Greenberg; Dita Gratzinger
Journal:  Lab Invest       Date:  2012-06-18       Impact factor: 5.662

7.  Bone marrow microenvironment in fanconi anemia: a prospective functional study in a cohort of fanconi anemia patients.

Authors:  Séverine Lecourt; Valérie Vanneaux; Thierry Leblanc; Gwenaelle Leroux; Brigitte Ternaux; Marc Benbunan; Christine Chomienne; Andé Baruchel; Jean-Pierre Marolleau; Eliane Gluckman; Gerard Socié; Jean Soulier; Jérôme Larghero
Journal:  Stem Cells Dev       Date:  2010-02       Impact factor: 3.272

8.  Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.

Authors:  Maria Ester Bernardo; Nadia Zaffaroni; Francesca Novara; Angela Maria Cometa; Maria Antonietta Avanzini; Antonia Moretta; Daniela Montagna; Rita Maccario; Raffaella Villa; Maria Grazia Daidone; Orsetta Zuffardi; Franco Locatelli
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

9.  Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome.

Authors:  O Lopez-Villar; J L Garcia; F M Sanchez-Guijo; C Robledo; E M Villaron; P Hernández-Campo; N Lopez-Holgado; M Diez-Campelo; M V Barbado; J A Perez-Simon; J M Hernández-Rivas; J F San-Miguel; M-C del Cañizo
Journal:  Leukemia       Date:  2009-01-08       Impact factor: 11.528

10.  CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance.

Authors:  Adam Greenbaum; Yen-Michael S Hsu; Ryan B Day; Laura G Schuettpelz; Matthew J Christopher; Joshua N Borgerding; Takashi Nagasawa; Daniel C Link
Journal:  Nature       Date:  2013-02-24       Impact factor: 49.962
View more
  11 in total

1.  Efficacy of ALK5 inhibition in myelofibrosis.

Authors:  Lanzhu Yue; Matthias Bartenstein; Wanke Zhao; Wanting Tina Ho; Ying Han; Cem Murdun; Adam W Mailloux; Ling Zhang; Xuefeng Wang; Anjali Budhathoki; Kith Pradhan; Franck Rapaport; Huaquan Wang; Zonghong Shao; Xiubao Ren; Ulrich Steidl; Ross L Levine; Zhizhuang Joe Zhao; Amit Verma; Pearlie K Epling-Burnette
Journal:  JCI Insight       Date:  2017-04-06

2.  Exploitation of the neural-hematopoietic stem cell niche axis to treat myeloproliferative neoplasms.

Authors:  Naoimh Herlihy; Claire N Harrison; Donal P McLornan
Journal:  Haematologica       Date:  2019-04       Impact factor: 9.941

Review 3.  An immune dysregulation in MPN.

Authors:  Giovanni Barosi
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

Review 4.  Regulation of Malignant Myeloid Leukemia by Mesenchymal Stem Cells.

Authors:  Zhenya Tan; Chen Kan; Mandy Wong; Minqiong Sun; Yakun Liu; Fan Yang; Siying Wang; Hong Zheng
Journal:  Front Cell Dev Biol       Date:  2022-06-08

Review 5.  The Bone Marrow Microenvironment in Health and Myeloid Malignancy.

Authors:  Marta Galán-Díez; Álvaro Cuesta-Domínguez; Stavroula Kousteni
Journal:  Cold Spring Harb Perspect Med       Date:  2018-07-02       Impact factor: 6.915

Review 6.  Cancer associated fibroblasts in hematological malignancies.

Authors:  Lizzia Raffaghello; Angelo Vacca; Vito Pistoia; Domenico Ribatti
Journal:  Oncotarget       Date:  2015-02-20

7.  Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis.

Authors:  Teresa L Ramos; Luis Ignacio Sánchez-Abarca; Beatriz Rosón-Burgo; Alba Redondo; Ana Rico; Silvia Preciado; Rebeca Ortega; Concepción Rodríguez; Sandra Muntión; Ángel Hernández-Hernández; Javier De Las Rivas; Marcos González; José Ramón González Porras; Consuelo Del Cañizo; Fermín Sánchez-Guijo
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

8.  HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?

Authors:  Teresa L Ramos; Luis Ignacio Sánchez-Abarca; Alba Redondo; Ángel Hernández-Hernández; Antonio M Almeida; Noemí Puig; Concepción Rodríguez; Rebeca Ortega; Silvia Preciado; Ana Rico; Sandra Muntión; José Ramón González Porras; Consuelo Del Cañizo; Fermín Sánchez-Guijo
Journal:  Oncotarget       Date:  2017-04-25

Review 9.  The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming.

Authors:  Noymar Luque-Campos; Felipe A Bustamante-Barrientos; Carolina Pradenas; Cynthia García; María Jesús Araya; Candice Bohaud; Rafael Contreras-López; Roberto Elizondo-Vega; Farida Djouad; Patricia Luz-Crawford; Ana María Vega-Letter
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

Review 10.  Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis.

Authors:  Christophe Desterke; Christophe Martinaud; Nadira Ruzehaji; Marie-Caroline Le Bousse-Kerdilès
Journal:  Mediators Inflamm       Date:  2015-11-12       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.